TNF and cystic fibrosis: As downregulating effects of azithromycin are evident on pro-inflammatory cytokine release responses in CF mice, we could postulate that the macrolide exerts its action in CF lung disease on inhibiting TNF-α release and in less extent MIP-2, possibly by inhibiting NFκB pathway.